4th International Conference on Blood Malignancies and Treatment
The Oberoi DubaiDubai, UAE Visit the Venue to read more
OMICS International is glad to welcome all the interested participants to its 4th International Conference on Blood Malignancies and Treatment during April 18-20, 2016 at Dubai, UAE.
Blood Malignancies 2016 will be an initiative to find the weapon to fight against the dreadful blood cancers, to protect and save lives. Discussions will be focused on the different types of blood cancers, possibility of early detection and treatment at the advanced stages of these cancers to prolong life.The conference will be organized around the theme “Conquering blood cancer with contemporary precision therapeutics and restorative approaches”. OMICS International Organizes 1000+ Scientific Conferences every year across USA, Europe & Asia. Besides 700 Peer reviewed, Open Access Journals, OMICS International has collaborated with more than 1000 Scientific Associations and institutions worldwide to promote information on health care and technologies. These journals are enjoying the support of over 7 million readers; a team of 50,000 eminent scholars are providing editorial support.
Blood cancer is a type of cancer or tumor. Blood cancer affects the blood, bone marrow, lymph, and lymphatic system, sometimes more than one body part gets affected. It affects the production and function of your blood cells. Most of these cancers start in your bone marrow where blood is produced. Billions of people are suffering from blood cancers and millions are dying every year across the globe. Blood cancer affects a large number of people. Every 20 minutes, one person in UK is detected with blood cancer, 70 people a day, and 25,000 people a year. According to the CDC, cancer is the second leading cause of mortality, causing 584,881 deaths worldwide in 2013. Early diagnosis is the key to prevent the rising number of cancer-related deaths. The global cancer diagnostics market is witnessing a rapid transformation owing to several technological advancements in diagnostic platforms such as next-generation sequencing, DNA microarrays, and polymerase chain reaction (PCR). Moreover, the market has seen the advent of hybrid imaging instruments with enhanced accuracy, such as PET/CT and SPECT/CT. These advancements have augmented the growth of the cancer diagnostics market. The global cancer diagnostics market is expected to reach $13.1 Billion in 2020 from an estimated $7.1 Billion in 2015, growing at a CAGR of 12.9%. The global tumor ablation market is poised to grow at a CAGR of 11.5% during 2014-2019, and is expected to reach a value of 462.0 Million in 2019.
Target Audience :
Research scholars working in the field of Blood Cancer
Student delegates from biomedical and healthcare sectors to be a part of it.
Medical Colleges on Blood Cancer Research
Hematology Associations & Societies
Manufacturing Medical Devices Companies
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
The Oberoi Dubai
Al A'amal Street Dubai United Arab Emirates
In today’s economic climate your business decisions are as crucial as ever. 4th International Conference on Blood Malignancies and Treatment allows you to maximize your time and marketing dollars while receiving immediate feedback on your new products and services.
4th International Conference on Blood Malignancies and Treatment is organizing an outstanding Scientific Exhibition/Program and anticipates the world’s leading specialists involved in .
Blood Malignancies 2016 organizing committee anticipates over 300 participants to attend this premier event. Your organization will benefit with excellent exposure to the leaders in Oncology & Cancer.
Blood Malignancies 2016 is an exciting opportunity to showcase the new technology, the new products of your company, and/or the service your industry may offer to a broad international audience.
Lots of thoughts were put together planning to make this conference a premier event. Our worldwide Editorial Board Members of Journal of Transplantation Technologies & Research, Journal of Leukemia and Journal of Cancer Science & Therapy have agreed to promote and support the event.
Exhibiting at 4th International Conference on Blood Malignancies and Treatment will attain you with an exceptional format in showcasing your products and services. OMICS International Conferences and Exhibitions provide you one location to reach your top customers.
Drop us an email for Program enquiry.
Sponsors / Exhibiting / Advertising.
- See more at: http://bloodmalignancies.conferenceseries.com/#sthash.zFUhio01.dpuf